The Japanese Journal of Nephrology and Pharmacotherapy
Online ISSN : 2189-8014
Print ISSN : 2187-0411
Case Report
Safety of Levetiracetam from differences in blood purification therapy
Toshiro Shiuchi Shinya MurakamiYasuyo SutoKazuhiko Kawahara
Author information
JOURNAL FREE ACCESS

2018 Volume 7 Issue 3 Pages 211-214

Details
Abstract

A 34 years old woman had a convulsive seizure about 7 months after introduction of hemodialysis(HD), and convulsive seizure disappeared when Levetiracetam was administered. For the purpose of preventing dialysis amyloidosis, we changed from HD to on-line hemodiafiltration(on-line HDF), but after the change there was a strong appeal of drowsiness. Since the symptoms of strong drowsiness could not be taken, treatment was restored from on-line HDF to HD and the symptoms improved, so the possibility that Levetiracetam removal was less in on-line HDF than HD was suspected to have accumulated.

Content from these authors
© 2018 The Japanese Society of Nephrology and Pharmacotherapy
Previous article
feedback
Top